CXCL8 and neoplasm: Neutralization of IL-8 with mAb could be also therapeutically feasible.This has been recently demonstrated in a situation in which tumor xenografts escapefrom sunitinib-induced anti-angiogenesis by means of an IL-8-dependent mechanism[19].